GH Research | 6-K:外国发行人报告
GH Research | 6-K:外国发行人报告
GH Research | 6-K:外国发行人报告(业绩相关)
GH Research | 6-K:外国发行人报告(业绩相关)
GH Research | 6-K:外国发行人报告
GH Research | 6-K:外国发行人报告
GH Research | 20-F:年度报告/过渡报告/注册声明
GH Research | 6-K:外国发行人报告(业绩相关)
GH Research | SC 13G:超过5%持股股东披露文件-Lynx1 Capital Management LP(5.8%),Weston Nichols(5.8%)
GH Research | SC 13G/A:超过5%持股股东披露文件(修正)-Venrock Healthcare Capital Partners II, L.P.(2.5%),VHCP Co-Investment Holdings II, LLC(2.5%)等
GH Research | SC 13G/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(10.7%),Peter Kolchinsky(10.7%)等
GH Research | SC 13G/A:超过5%持股股东披露文件(修正)-BVF Partners L.P.(19.99%),BVF Inc.(19.99%)等
GH Research | SC 13G:超过5%持股股东披露文件-RTW Investments, LP(6.4%),Roderick Wong, M.D.(6.4%)
GH Research | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(6.030%),Abigail P. Johnson(6.030%)
GH Research | 6-K:外国发行人报告
GH Research | 6-K:外国发行人报告
GH Research | 6-K:外国发行人报告
GH Research | 6-K:外国发行人报告(业绩相关)
GH Research | 6-K:外国发行人报告
GH Research | 6-K:外国发行人报告
暂无数据